Trial Profile
A Blinded, Randomized, Placebo-controlled Phase 1 Study in Healthy Male Adults to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Doses of ABT-072.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2010
Price :
$35
*
At a glance
- Drugs ABT 072 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 23 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2010 Additional trial lead investigator (Kazuko Kobayashi ) identified as reported by ClinicalTrials.gov.
- 07 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.